Trial
NCT00638196
Placebo vs. Linoleic Acid Controlled Assessment of Treatment Efficacy in MS
Phase ITERMINATEDOPERATIONALConfidence: HIGH
Sponsor
University of Rochester
Collaborators
—
Condition
Multiple Sclerosis
Intervention
Linoleic Acid/Oleic Acid
Why stopped
funding stopped due to slow enrollment.
Provenance
Dataset: 2026-07-02 • Source: ClinicalTrials.gov API v2 • Last update: 2015-08-11